University of California San Francisco

862 RashX: Immune single-cell transcriptional classification of human chronic inflammatory skin disease.

A. Hailer, Y. Liu, H. Wang, M. Taylor, C. Cook, J. North, T. Mauro, E. Purdom, J. Cheng, R. Cho PMID:

Generalized Pustular Psoriasis: A Review of the Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment. (36219603)

Reynolds KA, Pithadia DJ, Lee EB, Clarey D, Liao W, Wu JJ PMID: 36219603

Onset of Plaque Psoriasis Treatment Responses With Anti-IL-17/IL-23 Biologic Therapies. (35946972)

Fried R, Lebwohl M, Bettencourt M, Koo J, Jacobson A PMID: 35946972

544 Commensal induced accumulation of monocyte-derived cells in neonatal skin regulates long-term cutaneous type 17 inflammation.

M. Dhariwala, J. Okoro, T. Scharschmidt PMID:

561 Filaggrin deficiency confers an altered early life T cell response to commensal skin bacteria.

J. Gonzalez, T. Scharschmidt PMID:

"Normal" TEWL-how can it be defined? A systematic review. (35753062)

Green M, Feschuk AM, Kashetsky N, Maibach HI PMID: 35753062

Defining Patient-Level Molecular Heterogeneity in Psoriasis Vulgaris Based on Single-Cell Transcriptomics. (35958578)

Liu Y, Wang H, Cook C, Taylor MA, North JP, Hailer A, Shou Y, Sadik A, Kim E, Purdom E, Cheng JB, Cho RJ PMID: 35958578

Defining Patient-Level Molecular Heterogeneity in Psoriasis Vulgaris Based on Single-Cell Transcriptomics. (35958578)

Liu Y, Wang H, Cook C, Taylor MA, North JP, Hailer A, Shou Y, Sadik A, Kim E, Purdom E, Cheng JB, Cho RJ PMID: 35958578

Defining Patient-Level Molecular Heterogeneity in Psoriasis Vulgaris Based on Single-Cell Transcriptomics. (35958578)

Liu Y, Wang H, Cook C, Taylor MA, North JP, Hailer A, Shou Y, Sadik A, Kim E, Purdom E, Cheng JB, Cho RJ PMID: 35958578

Open-Label Adhesion Performance Study of a Prescription Lidocaine Topical System 1.8% versus Three Lidocaine-Containing Over-the-Counter Patches in Healthy Subjects. (35923843)

Fudin J, Vought K, Patel K, Lissin D, Maibach H PMID: 35923843